top of page
History
2022
2023
2020
2019
2017
2016
2015
• 510(K) cleared for Gen II, Neuroblade System
• Series B fund raising
• 510(K) cleared for Axonpen System
• Start FIM clinical trial in Chang Gang Memorial Hospital in Taiwan
• Series A fund raising
• Cadaver feasibility study completed
• Animal feasibility study completed
• Founded by Dr. Abel Huang in San Francisco, US by pitching to Y Combinator
• Seed round fund raising
bottom of page